www. algerleeseminars.com Button 1 Button 2

843-685-4177


The purpose of this seminar is to provide the participant with the most current information on the subjects being presented

The participant must attend at least 85% of the session to get credit for that session.

The Speakers have no conflicts of interests. 

Subjects and/or Speakers may change without notice.

30 mAY- 1 JUNE 2024
Conference Agenda
Day 1

Thursday, 30 May 2024

7:15-7:45

Registration

Barbara Lee Williamson, FNP, MSN

7:45-7:800

Introductions

Constance Alger, FNP, MSN, MSEd

8:00-9:30

Utilizing ACE's in Primary Care

Deborah Hopla, DNP, APRN-BC

9:30-9:45

Break

9:45-11:15

Palliative Care and Hospice

Donald I. Lowe, MSN, BA, AGPCNP-BC

11:15-11:45

Break - Lunch Setup
Day 1

Thursday, 30 May 2024

11:45-1:15 - LUNCH LECTURE

Tobacco Cessation 

Nancy Plemmons, FNP

1:15-1:30

Break

1:30-3:00

Telomers & Nitrates

B. Lee Williamson, MSN, FNP

3:00-3:15

Break

3:15-4:45

Parkinson's Disease 

Leslie Norris, DNP, FNP-C

4:45-5:00

Evaluations

5:00-6:30

Reception
31 May 2024
Conference Agenda
Day 2

Thursday, 31 May 2024

7:30-7L45

Registration

Barbara Lee Williamson, FNP, MSN

7:45-7:800

Introductions

Constance Alger, FNP, MSN, MSEd

8:00-9:30

Dementia

Leslie Norris, DNP, FNP-C

9:30-9:45

Break

9:45 - 11:15

Emerging Therapies and Strategies for Dealing with Behavioral Health

David Justice, MD

11:15-11:45

Break - Lunch Setup
Day 2

Thursday, 31 May 2024

11:45-1:15 - LUNCH LECTURE

Renal Disease

Spencer A. Morris, Pharm D., BCPS

1:15-1:30

Seminar Evaluations

2:00-4:30 - OPTIONAL SESSION

Coding Workshop

Kelly Ann Larocca

1 june 2024
Conference Agenda
Day 3

Saturday, 1 June 2024

7:30-7:45

Registration

Barbara Lee Williamson, FNP, MSN

7:45-8:00

Introductions

Constance Alger, FNP, MSN, MSEd

8:00-9:30

PAIN MANAGMENT

Deborah Hopla, DNP, APRN-BC

9:30-9:45

Break
Day 3

Saturday, j June 2024

9:45-11:45

Obesity Drugs

Kelly Jones, Pharm D.

11:45-12:15

Break - Lunch Setup
12:15-2:15
COPD - New GOLD Standards

Kelly Jones, Pharm D.

2:15-2:30

Evaluations